The rising median age of people around the world has the same effect, since cancer can take decades to develop and therefore ...

EXCLUSIVE: The Nolans' Anne Nolan opens up on her cancer battle and admits she feels 'lucky' to be alive after being given the all clear following a 'terrible' 2022 ...

AIIMS Bilaspur aims to transform healthcare in Himachal Pradesh, featuring significant advancements in infrastructure, cancer treatment, and trauma care, while ensuring residents receive top-tier ...

Their first product, Illuccix, is a diagnostic imaging agent that allows PET scanners to light up the prostate cancer cells ...

In a significant advancement for prostate cancer research, a first-of-its-kind study led by Emory researchers uncovered how ...

Pharmaceutical scientists, clinicians, nurses and pharmacists from the National University of Singapore (NUS) and National ...

Results of a study led by VHIO’s Prostate Cancer Group suggest that treatment with CDK4/6 inhibitors followed by senloytic ...

Men on active surveillance for low- to intermediate-risk prostate cancer (PCa) have low risk for PCa-related mortality at a median follow-up of 18 years. However, a majority of men do progress and ...

Research confirms that many men with nonmetastatic prostate cancer will not die of their disease once they received recommended treatment.

Most men who are treated for prostate cancer according to modern guidelines have good survival rates and the majority of ...

Men diagnosed with nonmetastatic low- and intermediate-risk prostate cancer up to 6 times more likely to die of other causes.